Sign in to FlowVella

Forgot password?
Sign in with Facebook

New? Create your account

Sign up for FlowVella

Sign up with Facebook

Already have an account? Sign in now


By registering you are agreeing to our
Terms of Service

Share This Flow

Loading Flow

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

DISCUSSION

由于经济和医疗系统, 除了阿司匹林,氯吡格雷仍然是最广泛使用的抗血小板药物在ACS。许多个人经验,出现氯吡格雷抵抗,导致不良血栓事件。虽然研究表明,氯吡格雷治疗失败的最常见原因是药物依从性差,但是对氯吡格雷反应的个体性差异也是一个重要原因,在30 - 40 %的患者接受氯吡格雷治疗。作为另一个P2Y12R抑制剂(替格瑞洛)正在成为一个强大的竞争对手。

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...

Downloading Image /

loading...
  • 1

  • 2

  • 3

  • 4

  • 5

  • 6

  • 7

  • 8

  • 9

  • 10

  • 11

  • 12

  • 13

  • 14

  • 15

  • 16

  • 17

  • 18

  • 19

  • 20

  • 21

  • 22

  • 23

  • 24

  • 25

  • 26

  • 27

  • 28

  • 29

  • 30

  • 31

  • 32

  • 33

  • 34

  • 35

  • 36

  • 37

  • 38

  • 39

  • 40

  • 41

  • 42

  • 43

  • 44

  • 45

  • 46

心脏病生理学 替格瑞洛

By Bill Ho